{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:50:35Z","timestamp":1792234235001,"version":"4.4.0"},"reference-count":58,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Cardiac amyloidosis (CA) is a rare but potentially life-threatening disease in which misfolded proteins accumulate in the cardiac wall tissue. Heart rhythm disorders in CA, including supraventricular arrhythmias, conduction system disturbances, or ventricular arrhythmias, play a major role in CA morbidity and mortality, and thus require supplementary management. Among them, AF is the most frequent arrhythmia during CA hospitalizations and is associated with significantly higher mortality, while ventricular arrhythmias are also common and are usually associated with poor prognosis. Early diagnosis of potential arrythmias could be performed through ECG, Holter monitoring, and\/or electrophysiology study. Clinical management of these patients is quite significant, and it usually includes initiation of amiodarone and\/or digoxin in patients with AF, potential electrical cardioversion, or ablation in specific patients with indication, as well as initiation of anticoagulants in all patients, independent of AF and CHADS-VASc score, for potential intracardiac thrombus. Moreover, identification of patients with conduction disorders that could benefit from prophylactic pacemaker implantation and\/or CRT as well as identification of patients with life-threatening ventricular arrythmias that could benefit from ICD could both increase the survival rates of these patients and improve their quality of life.<\/jats:p>","DOI":"10.3390\/jcdd10080337","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T10:21:39Z","timestamp":1691230899000},"page":"337","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Arrhythmias in Patients with Cardiac Amyloidosis: A Comprehensive Review on Clinical Management and Devices"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-9670","authenticated-orcid":false,"given":"Alexandros","family":"Briasoulis","sequence":"first","affiliation":[{"name":"Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4348-2153","authenticated-orcid":false,"given":"Christos","family":"Kourek","sequence":"additional","affiliation":[{"name":"Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamantia","family":"Papamichail","sequence":"additional","affiliation":[{"name":"Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Loritis","sequence":"additional","affiliation":[{"name":"Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Bampatsias","sequence":"additional","affiliation":[{"name":"Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Repasos","sequence":"additional","affiliation":[{"name":"Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9439-3946","authenticated-orcid":false,"given":"Andrew","family":"Xanthopoulos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Tsougos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hygeia Hospital, 15123 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Paraskevaidis","sequence":"additional","affiliation":[{"name":"Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2007.10.016","article-title":"Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death","volume":"5","author":"Kristen","year":"2008","journal-title":"Heart Rhythm"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1136\/hrt.2009.190405","article-title":"Amyloid diseases of the heart: Assessment, diagnosis, and referral","volume":"97","author":"Dubrey","year":"2011","journal-title":"Heart"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1179546820963055","DOI":"10.1177\/1179546820963055","article-title":"Ventricular Arrhythmias in Cardiac Amyloidosis: A Review of Current Literature","volume":"14","author":"Khanna","year":"2020","journal-title":"Clin. Med. Insights Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e12967","DOI":"10.1111\/anec.12967","article-title":"Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis","volume":"27","author":"Ng","year":"2022","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.amjcard.2020.12.024","article-title":"Impact of Arrhythmias on Hospitalizations in Patients With Cardiac Amyloidosis","volume":"143","author":"Thakkar","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Argir\u00f2, A., Del Franco, A., Mazzoni, C., Allinovi, M., Tomberli, A., Tarquini, R., Di Mario, C., Perfetto, F., Cappelli, F., and Zampieri, M. (2022). Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not. Biomedicines, 10.","DOI":"10.3390\/biomedicines10112888"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Laptseva, N., Rossi, V.A., Sudano, I., Schwotzer, R., Ruschitzka, F., Flammer, A.J., and Duru, F. (2023). Arrhythmic Manifestations of Cardiac Amyloidosis: Challenges in Risk Stratification and Clinical Management. J. Clin. Med., 12.","DOI":"10.3390\/jcm12072581"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/anec.12032","article-title":"Prevalence and prognostic value of conduction disturbances at the time of diagnosis of cardiac AL amyloidosis","volume":"18","author":"Boldrini","year":"2013","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e006619","DOI":"10.1161\/CIRCHEARTFAILURE.119.006619","article-title":"Baseline ECG Features and Arrhythmic Profile in Transthyretin Versus Light Chain Cardiac Amyloidosis","volume":"13","author":"Cappelli","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13506129.2015.1028616","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: Prevalence, incidence, risk factors and prognostic role","volume":"22","author":"Longhi","year":"2015","journal-title":"Amyloid"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of Arrhythmias in Cardiac Amyloidosis","volume":"6","author":"Giancaterino","year":"2020","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.19102\/icrm.2018.090301","article-title":"Arrhythmias in Cardiac Amyloidosis","volume":"9","author":"John","year":"2018","journal-title":"J. Innov. Card. Rhythm Manag."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/13506129.2019.1620724","article-title":"Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: Clinical and echocardiographic features, impact on mortality","volume":"26","author":"Sanchis","year":"2019","journal-title":"Amyloid"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Assaf, A., Mekhael, M., Noujaim, C., Chouman, N., Younes, H., Kreidieh, O., Marrouche, N., and Donnellan, E. Conduction system disease in cardiac amyloidosis. Trends Cardiovasc. Med., 2023. in press.","DOI":"10.1016\/j.tcm.2023.02.004"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","article-title":"Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies","volume":"6","author":"Donnellan","year":"2020","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.hrthm.2015.09.016","article-title":"Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy","volume":"13","author":"Barbhaiya","year":"2016","journal-title":"Heart Rhythm"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/01.CIR.0000034511.06350.DF","article-title":"Atrial amyloidosis: An arrhythmogenic substrate for persistent atrial fibrillation","volume":"106","author":"Peters","year":"2002","journal-title":"Circulation"},{"key":"ref_18","first-page":"e9842","article-title":"Association of Arrhythmias in Cardiac Amyloidosis and Cardiac Sarcoidosis","volume":"12","author":"Ashraf","year":"2020","journal-title":"Cureus"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Rapezzi","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jacep.2019.10.013","article-title":"No Association Between CHADS-VASc Score and Left Atrial Appendage Thrombus in Patients with Transthyretin Amyloidosis","volume":"5","author":"Donnellan","year":"2019","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.36660\/abchf.20210035","article-title":"Ventricular Arrythmias in Cardiac Amyloidosis: It is Possible to Prevent Sudden Death?","volume":"1","author":"Dumont","year":"2021","journal-title":"ABC Heart Fail. Cardiomyop."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1046\/j.1460-9592.2001.01228.x","article-title":"Holter monitoring in AL amyloidosis: Prognostic implications","volume":"24","author":"Palladini","year":"2001","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2009.05.040","article-title":"Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring","volume":"104","author":"Goldsmith","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Martini, N., Sinigiani, G., De Michieli, L., Mussinelli, R., Perazzolo Marra, M., Iliceto, S., Zorzi, A., Perlini, S., Corrado, D., and Cipriani, A. Electrocardiographic features and rhythm disorders in cardiac amyloidosis. Trends Cardiovasc. Med., 2023. in press.","DOI":"10.1016\/j.tcm.2023.02.006"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey","year":"1998","journal-title":"QJM"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.amjcard.2021.07.028","article-title":"Management Strategies for Atrial Fibrillation and Flutter in Patients with Transthyretin Cardiac Amyloidosis","volume":"157","author":"Dale","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/CIRCRESAHA.116.304521","article-title":"The spectrum of epidemiology underlying sudden cardiac death","volume":"116","author":"Hayashi","year":"2015","journal-title":"Circ. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jacep.2021.01.022","article-title":"Incidence and Predictors of Sudden Cardiac Arrest in Sarcoidosis: A Nationwide Analysis","volume":"7","author":"Narasimhan","year":"2021","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Lindow, T., and Lindqvist, P. (2021). The Prevalence of Advanced Interatrial Block and Its Relationship to Left Atrial Function in Patients with Transthyretin Cardiac Amyloidosis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132764"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0735-1097(97)00267-2","article-title":"Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement","volume":"30","author":"Reisinger","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0002-9149(83)90084-X","article-title":"Cardiac amyloidosis causing cardiac dysfunction: Analysis of 54 necropsy patients","volume":"52","author":"Roberts","year":"1983","journal-title":"Am. J. Cardiol."},{"key":"ref_32","first-page":"1474","article-title":"Sudden death in lambda light chain AL cardiac amyloidosis: A review of literature and update for clinicians and pathologists","volume":"13","author":"Mazzanti","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cjca.2019.11.039","article-title":"Arrhythmias in Cardiac Amyloidosis: Challenges in Risk Stratification and Treatment","volume":"36","author":"Cheung","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2018.10.079","article-title":"Direct Current Cardioversion of Atrial Arrhythmias in Adults with Cardiac Amyloidosis","volume":"73","author":"Dispenzieri","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System","volume":"68","author":"Grogan","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_36","first-page":"e210","article-title":"2017 AHA\/ACC\/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"138","author":"Stevenson","year":"2018","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0002-9149(97)82785-3","article-title":"Symptomatic conduction system disease in cardiac amyloidosis","volume":"80","author":"Mathew","year":"1997","journal-title":"Am. J. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/europace\/euz314","article-title":"Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis","volume":"22","author":"Donnellan","year":"2020","journal-title":"Europace"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijcard.2022.04.045","article-title":"Routine ambulatory heart rhythm monitoring for detection of atrial arrhythmias in transthyretin cardiac amyloidosis","volume":"358","author":"Dale","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ehf2.13701","article-title":"Thromboembolism and bleeding in systemic amyloidosis: A review","volume":"9","author":"Nicol","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13506120500537285","article-title":"Natural history of thromboembolism in AL amyloidosis","volume":"13","author":"Halligan","year":"2006","journal-title":"Amyloid"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"742428","DOI":"10.3389\/fcvm.2021.742428","article-title":"New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients with Cardiac Amyloidosis: Prognostic Impact","volume":"8","author":"Cariou","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/00015385.2017.1335034","article-title":"Cardiac amyloidosis: Pathogenesis, clinical context, diagnosis and management options","volume":"72","author":"Alkhawam","year":"2017","journal-title":"Acta Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/2632463621998583","article-title":"Cardiac Amyloidosis Wild Type (ATTR-CAwt) and Associated Cardiac Arrhythmias: A Case Report and Literature Review","volume":"2","author":"Nagarakanti","year":"2021","journal-title":"Indian J. Clin. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00059-020-04904-4","article-title":"Amyloid cardiomyopathy","volume":"45","author":"Kristen","year":"2020","journal-title":"Herz"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/jce.12123","article-title":"Implantable cardioverter defibrillators in patients with cardiac amyloidosis","volume":"24","author":"Lin","year":"2013","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.amjcard.2020.05.021","article-title":"Prevalence, incidence, and impact on mortality of conduction system disease in transthyretin cardiac amyloidosis","volume":"128","author":"Donnellan","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1111\/jce.14180","article-title":"Cardiac devices in patients with transthyretin amyloidosis: Impact on functional class, left ventricular function, mitral regurgitation, and mortality","volume":"30","author":"Donnellan","year":"2019","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.hrthm.2012.02.033","article-title":"Prophylactic pacemaker implantation in familial amyloid polyneuropathy","volume":"9","author":"Algalarrondo","year":"2012","journal-title":"Heart Rhythm"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/ehf2.13443","article-title":"Progress and challenges in the treatment of cardiac amyloidosis: A review of the literature","volume":"8","author":"Adam","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/eurheartj\/ehu506","article-title":"A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis","volume":"36","author":"Sayed","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cjca.2019.12.002","article-title":"Use of Implantable Electronic Devices in Patients With Cardiac Amyloidosis","volume":"36","author":"John","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijcard.2016.07.254","article-title":"Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis","volume":"222","author":"Hamon","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/bjh.14747","article-title":"Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis","volume":"182","author":"Rezk","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2013.10.026","article-title":"Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis","volume":"11","author":"Varr","year":"2014","journal-title":"Heart Rhythm"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00695078","article-title":"The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden","volume":"402","author":"Eriksson","year":"1984","journal-title":"Virchows Arch. A. Pathol. Anat. Histopathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1540-8159.1984.tb05599.x","article-title":"Pacemaker treatment in familial amyloidosis with polyneuropathy","volume":"7","author":"Eriksson","year":"1984","journal-title":"Pacing Clin. Electrophysiol."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/10\/8\/337\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:26:17Z","timestamp":1760127977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/10\/8\/337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,5]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["jcdd10080337"],"URL":"https:\/\/doi.org\/10.3390\/jcdd10080337","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,5]]}}}